Ipsen
Trending Articles
Related Content
Regulatory
Somatuline Autogel receives Japanese approval for tumour treatment
Ipsen and Teijin Pharma, has received approval from the Japanese Ministry of Health, Labour and Welfare for Ipsen's subcutaneous drug Somatuline (lanreotide) for the treatment of gastroenteropancreatic neuroendocrine tumours